While brief exposure during shipping rarely causes problems, prolonged storage at room temperature significantly reduces potency
2 mg once weekly represents the most commonly reported starting point in published Phase 2 data, not a universally fixed starting dose
In newer Phase 3 data, retatrutide produced substantial average body weight reduction at higher studied doses, reinforcing why the medication has attracted significant attention in obesity medicine
Clin Pharmacokinet
For health-minded consumers, its about trading up in various categories, shown in the bar chart
After three years, there was a 30% reduction in emergency department visits, 25% reduction in hospitalizations, 40% reduction in overdose and 50% reduction in drug-related deaths